Very short-term effects of a single dose of a proprotein convertase subtilisin/kexin 9 inhibitor before percutaneous coronary intervention: A single-arm study
A single dose of the PCSK9 inhibitor administered before PCI reduced the abundance of lipid-core plaques identified via NIRS-IVUS at target lesions within a very short period of 2-6 weeks.
Authors
- Yusuke Sato (ORCID: https://orcid.org/0000-0003-2897-4766)
- Machiko Miyoshi (ORCID: https://orcid.org/0000-0002-7486-750X)
- Hiroyuki Ikeda (ORCID: https://orcid.org/0000-0001-5710-7456)
- Tomohiro Shimizu (ORCID: https://orcid.org/0000-0001-6760-3066)
- Hiroyasu Uzui (ORCID: https://orcid.org/0000-0001-7634-6911)
- Kanae Hasegawa (ORCID: https://orcid.org/0000-0003-0517-0255)
- Yuichiro Shiomi
- Kentaro Ishida (ORCID: https://orcid.org/0000-0002-2365-2509)
- Tetsuji Morishita (ORCID: https://orcid.org/0000-0002-7225-2819)
- Hiroshi Tada (ORCID: https://orcid.org/0000-0001-8578-2328)
- Junya Yamaguchi (ORCID: https://orcid.org/0000-0001-6616-3644)
- Tatsuhiro Kataoka (ORCID: https://orcid.org/0000-0002-4015-3365)
- Naoto Tama (ORCID: https://orcid.org/0000-0002-8930-5606)
Institutions
- University of Fukui (JP)
- Matsunami General Hospital (JP)
- University of Fukui Hospital (JP)
Publication Details
- Journal
- Atherosclerosis
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1016/j.atherosclerosis.2024.118581
- Citations
- 4
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 2.29